These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4048132)

  • 1. [Use of ultrasonic inhalation of antibacterial preparations in the complex treatment of children and adolescents with tuberculosis of the organs of respiration].
    Aksenova VA
    Probl Tuberk; 1985; (7):27-9. PubMed ID: 4048132
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis of the upper respiratory tract.
    Chodosh PL; Willis W
    Laryngoscope; 1970 May; 80(5):679-96. PubMed ID: 5452508
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of antibacterial therapy on the state of the mucous membrane of the upper respiratory tract and ears in lupus patients].
    Podgaetskiĭ GB
    Zh Ushn Nos Gorl Bolezn; 1964; 24(6):39-42. PubMed ID: 5876600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of ultrasonic aerosols in phthisiology and pulmonology].
    Pilipchuk NS; Protsiuk RG
    Klin Med (Mosk); 1986 Dec; 64(12):36-40. PubMed ID: 3560800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and early diagnosis of tuberculosis of the respiratory organs in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Il'nitskiĭ IG; Nikolaeva OD; Moskovenko ED
    Probl Tuberk; 1986; (10):3-6. PubMed ID: 3492714
    [No Abstract]   [Full Text] [Related]  

  • 6. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis risk groups among children and principles of approach to chemoprophylaxis].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Kufakova GA; Demeshko ND
    Probl Tuberk; 1996; (3):10-12. PubMed ID: 8754865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with the treatment of pulmonary tuberculosis with INH--ultrasonic aerosols].
    PICKROTH G
    Dtsch Gesundheitsw; 1960 Aug; 15():1668-73. PubMed ID: 13735486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reserves for enhancing the efficiency of treatment for pulmonary tuberculosis in adolescents].
    Guseĭnov GK; Pakhieva KhIu; Balashova NA
    Probl Tuberk Bolezn Legk; 2006; (1):16-9. PubMed ID: 16512179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of tuberculosis in 100 children. A 5-year follow-up].
    Karam-Bechara J; Naime-Libien JE; Posada-Maldonado EE; Aroch-Calderón A; Olvera R
    Salud Publica Mex; 1994; 36(1):30-5. PubMed ID: 8042069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephaloridine by inhalation.
    Kennedy RS
    Postgrad Med J; 1967 Aug; 43():Suppl 43:51-2. PubMed ID: 6052331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tuberculosis in children and adolescents in orphanage and boarding schools and optimization of its prevention].
    Mitinskaia LA; Ivanova ES; Kufakova GA
    Probl Tuberk; 1993; (5):2-4. PubMed ID: 8295878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance to treatment of latent tuberculosis infection in a region of Israel.
    Bibi H; Weiler-Ravell D; Shoseyov D; Feigin I; Arbelli Y; Chemtob D
    Isr Med Assoc J; 2002 Jan; 4(1):13-6. PubMed ID: 11802301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficiency of preventive chemotherapy in children and adolescents from the bacterial isolation foci of tuberculous infection].
    Ovsiankina ES; Kasimtseva OV; Vasil'eva IA
    Probl Tuberk Bolezn Legk; 2006; (1):3-6. PubMed ID: 16512175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.
    McIlleron H; Willemse M; Werely CJ; Hussey GD; Schaaf HS; Smith PJ; Donald PR
    Clin Infect Dis; 2009 Jun; 48(11):1547-53. PubMed ID: 19392636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new antibiotic Rifampicin in the therapy of infectious diseases with special reference to acute respiratory tract infections].
    Galeone A; Verderio M
    Minerva Med; 1969 Dec; 60(96):4803-11. PubMed ID: 5357546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Features of the course of newly diagnosed tuberculosis of the respiratory organs in adolescents and efficacy of their treatment].
    Burlachenko MA; Baĭl'dinova IM
    Probl Tuberk; 1985; (7):37-40. PubMed ID: 4048135
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid resistance among tuberculosis patients by birth cohort in Germany.
    Forssbohm M; Loddenkemper R; Rieder HL
    Int J Tuberc Lung Dis; 2003 Oct; 7(10):973-9. PubMed ID: 14552568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of tuberculosis.
    Horne NW
    Practitioner; 1967 Oct; 119(192):465-72. PubMed ID: 4168646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.